Latest

Wall Street Journal: Merck’s Covid-19 Drug Is a Boon for Wall Street and Main Street

Coherus and Junshi announces positive interim data for pivotal trial in esophageal cancer

CalciMedica Reports Topline Data from the Auxora CARDEA Phase 2 COVID-19 Pneumonia Clinical Trial

Atea Announces Publication of Data Highlighting AT-752’s Potent Activity Against Dengue and Other Flaviviruses

COVID-19 viral biotech Atea Pharmaceuticals prices upsized IPO at $24 high end